首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Going both ways: Immune regulation via CD1d-dependent NKT cells
【2h】

Going both ways: Immune regulation via CD1d-dependent NKT cells

机译:双向:通过CD1d依赖性NKT细胞进行免疫调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

NKT cells are a unique T lymphocyte sublineage that has been implicated in the regulation of immune responses associated with a broad range of diseases, including autoimmunity, infectious diseases, and cancer. In stark contrast to both conventional T lymphocytes and other types of Tregs, NKT cells are reactive to the nonclassical class I antigen–presenting molecule CD1d, and they recognize glycolipid antigens rather than peptides. Moreover, they can either up- or downregulate immune responses by promoting the secretion of Th1, Th2, or immune regulatory cytokines. This review will explore the diverse influences of these cells in various disease models, their ability to suppress or enhance immunity, and the potential for manipulating these cells as a novel form of immunotherapy.
机译:NKT细胞是独特的T淋巴细胞亚系,已参与与多种疾病(包括自身免疫,传染病和癌症)相关的免疫反应的调节。与常规T淋巴细胞和其他类型的Treg形成鲜明对比的是,NKT细胞对非经典I类抗原呈递分子CD1d具有反应性,并且它们识别糖脂抗原而不是肽。而且,它们可以通过促进Th1,Th2或免疫调节细胞因子的分泌来上调或下调免疫反应。这篇综述将探讨这些细胞在各种疾病模型中的各种影响,它们抑制或增强免疫力的能力以及操纵这些细胞作为新型免疫疗法的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号